From: A review on exosomes application in clinical trials: perspective, questions, and challenges
EVs | Size | Markers | Mechanism of biogenesis |
---|---|---|---|
Exosomes | 30–150 nm | CD63, CD9, CD81, Tsg101 | Generated by inward budding of the membrane of MVBs through ESCRT-dependent Or/and ESCRT-independent and released into the ECM upon fusion of MVBs with the plasma membrane |
Exomeres |  < 50 nm | Unknown | Unknown |
Microvesicles or ectosomes | 100–1000 nm | ARF6, Annexin A1 | pinching off from membrane protrusions/the plasma membrane shedding |
Apoptotic bodies | 50–5000 nm | Phosphatidylserine | Generated from apoptotic cells following stimulation of apoptosis-related pathways |